Davis Polk advised the joint book-running managers in connection with the $138 million initial public offering of common stock of Global Blood Therapeutics, Inc. Global Blood’s common stock is listed on The NASDAQ Global Select Market under the symbol “GBT.”

Based in South San Francisco, California, Global Blood is a clinical stage biopharmaceutical company dedicated to discovering, developing and commercializing novel, small molecule therapeutics to treat grievous, non-malignant blood-based disorders with significant unmet need, including sickle cell disease.

The Davis Polk corporate team included partner Bruce K. Dallas and associates Mohammad Ali and Stephanie Lai. The tax team included partner Rachel D. Kleinberg and associate Nicole P. Field. The intellectual property team included partner Pritesh P. Shah and associate Fiona Finlay-Hunt. Counsel Marcie A. Goldstein provided FINRA advice. Members of the Davis Polk team are based in the Northern California and New York offices.

Copy link to share post